Science and Tech

Alzheimer's Disease Drug Market Growth 2019-2024


Alzheimer's Disease Drug7759.jpg

Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia.

In the last several years, global market of alzheimer’s disease drug change huge.

The classification of alzheimer’s disease drug includes Memantine, Donepezil, Rivastigmine and Others, and the proportion of Memantine in 2016 is about 49.28%. The market for Donepezil, is decreast quickly in past five years.

Alzheimer’s disease drug are widely used for Early to Moderate, Moderate to Severe stage treatment. The most proportion of alzheimer’s disease drug used to Moderate to Severe, and the market share in 2016 is 55.82%.

According to this study, over the next five years the Alzheimer's Disease Drug market will register a -11.3% CAGR in terms of revenue, the global market size will reach US$ 1580 million by 2024, from US$ 2870 million in 2019. 

In particular, this report presents the global market share (sales and revenue) of key companies in Alzheimer's Disease Drug business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Alzheimer's Disease Drug market by product type, application, key manufacturers and key regions and countries.

This study considers the Alzheimer's Disease Drug value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.

  • Donepezil
  • Memantine
  • Rivastigmine

Report Sample includes:
- Table of Contents
- List of Tables & Figures
- Charts
- Research Methodology

Get FREE Sample of this Report at https://www.24marketreports.com/report-sample/global-alzheimers-disease-drug-2019-2024-36

Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.

  • Early to Moderate Stages
  • Moderate to Severe Stages

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

  • Americas
  • United States
  • Canada
  • Mexico
  • Brazil
  • APAC
  • China
  • Japan
  • Korea

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

  • Allergan
  • Eisai
  • Novartis
  • Daiichi Sankyo
  • Merz Pharma
  • Pfizer
  • Johnson & Johnson
  • Lundbeck

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

  • To study and analyze the global Alzheimer's Disease Drug consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
  • To understand the structure of Alzheimer's Disease Drug market by identifying its various subsegments.
  • Focuses on the key global Alzheimer's Disease Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
  • To analyze the Alzheimer's Disease Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
  • To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
  • To project the consumption of Alzheimer's Disease Drug submarkets, with respect to key regions (along with their respective key countries).
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
  • To strategically profile the key players and comprehensively analyze their growth strategies.

Get the Complete Report & TOC at https://www.24marketreports.com/life-sciences/global-alzheimers-disease-drug-2019-2024-36

CONTACT US:
276 5th Avenue, New York , NY 10001,United States
International: (+1) 646 781 7170
Email: [email protected]

Follow Us On linkedin :- https://www.linkedin.com/company/24-market-reports




Avni Rane - 24 Market Reports



24MarketReports is the marque of market research industry which identifies massive database of market research reports. We are having a numerous sectors market research gathering which covers diverse verticals around the Earth. Our central focus to make it trouble-free for decision makers to find applicable information and locate right Research reports which can save their time and assist in what they do best.